Own a Piece of True Leaf. Click Here.

True Leaf Medicine Announces Listing on German Stock Exchanges

True Leaf Medicine Announces Listing on German Stock Exchanges

True Leaf Medicine International Ltd. (CSE: MJ) (Germany: TLA; WKN: A14NM1) (“True Leaf”) wishes to announce that its common shares are now listed and trading on the German stock exchanges in Frankfurt, Berlin and Munich under the symbol TLA. True Leaf anticipates that this listing will provide the company with increased visibility for its activities in all European capital markets.

True Leaf has appointed Bank M as its designated sponsor on the Frankfurt Stock Exchange. Designated sponsors secure higher liquidity and a better pricing by quoting binding prices for buying and selling shares on the electronic trading platform XETRA”

Darcy Bomford, CEO of True Leaf stated, “We are excited by this new listing as we anticipate the European investment community will have a large appetite for our unique Quality of Life vision for both people and pets.”

As True Leaf awaits the approval of its license application, the company is looking to enter the pet industry with a line of pet products focused on hemp nutrition, in conjunction with the development of a veterinary-approved cannabis-based pet medication.

The ISIN number for True Leaf is CA89785C1077 and the German Security Code (WKN) is A14NM1.

About True Leaf International Ltd.True Leaf Medicine International Ltd. has filed an application under Health Canada’s Marihuana for Medicinal Purposes Regulations (MMPR) to become a licensed producer with a facility located in the Village of Lumby, BC. The company has passed through the preliminary and enhanced screening process of Health Canada’s review and is currently awaiting a ‘ready-to-build’ approval.

For more information, please see True Leaf’s website.

Investor Inquiries
Kevin Bottomley
Director
778.389.9933
kevin@trueleaf.com

On Behalf of the Board of Directors

True Leaf Medicine International Ltd.

Michael Harcourt
Chairman

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.


FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.




Also in Press Releases

True Leaf Medicine International Ltd. Secures DTC Eligibility in the United States
True Leaf Medicine International Ltd. Secures DTC Eligibility in the United States

True Leaf Medicine International Ltd. (“True Leaf”) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), a company involved in the hemp and cannabis-based product industry, has secured DTC eligibility for its common shares from The Depository Trust Company (DTC) effective October 10, 2017.

Continue Reading

True Leaf Engages Boustead Securities to Underwrite Regulation A+ Offering
True Leaf Engages Boustead Securities to Underwrite Regulation A+ Offering

True Leaf has engaged Boustead Securities, LLC Member: FINRA/SIPC (“Boustead”), as lead underwriter. “Boustead looks forward to working with True Leaf’s team to bring their Regulation A+ offering to investors,” commented David Dobkin of Boustead.

Continue Reading

True Leaf Acquires Option to Purchase 40-Acre Site in Lumby, B.C.
True Leaf Acquires Option to Purchase 40-Acre Site in Lumby, B.C.

True Leaf Medicine International Ltd. has acquired an option to purchase the 40 acres of land that encompasses its facility in Lumby, B.C., through its wholly-owned subsidiary True Leaf Medicine Inc.

Continue Reading